We are hiring! Manager – Communications & events – Apply now!

Job offers, News & Events

ABOUT CQDM Since its inception, CQDM has raised more than $275 million to fund the development of 150 + drugs addressing major health challenges, including cancer, neurodegenerative and metabolic diseases. CQDM is a biopharmaceutical research consortium whose mission is to fund the development of innovative tools and technologies that accelerate the development of safe and effective drugs. We bring together … Read More

We are hiring! Project Manager – Apply now!

Job offers, News & Events

ABOUT CQDM Since its inception, CQDM has raised more than $275 million to fund the development of 150 + drugs addressing major health challenges, including cancer, neurodegenerative and metabolic diseases. CQDM is a biopharmaceutical research consortium whose mission is to fund the development of innovative tools and technologies that accelerate the development of safe and effective drugs. We bring together … Read More

Axelys and the sector-based industrial research clusters are joining forces to boost innovation in Quebec for the benefit of research centers, businesses and society.

News & Events

Montréal, le 8 février 2023 – Axelys, la société de développement et de transfert des innovations issues de la recherche publique du Québec ainsi que les neuf (9) regroupements sectoriels de recherche industrielle (RSRI) composés de : CQDM, CQRDA, CRIAQ, CRIBIQ, CRITM, InnovÉÉ, MEDTEQ+, PRIMA Québec et Prompt, tous mandatés par le ministère de l’Économie, de l’Innovation et de l’Énergie (MEIE), sont … Read More

CQDM and Defence Therapeutics fund the development of a new cancer vaccine platform

News & Events

Montreal, Quebec, February 2, 2023 – In celebration of World Cancer Day, CQDM is proud to announce the launch of a collaborative research project between Université de Montréal (UdeM), the Lady Davis Institute of the Jewish General Hospital and Defence Therapeutics, a Quebec-based biotechnology company specialized in the development of next-generation vaccines. The funding of this study, totalling $1,359,851, was … Read More